| __timestamp | Alnylam Pharmaceuticals, Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 91813000 |
| Thursday, January 1, 2015 | 41097000 | 178203000 |
| Friday, January 1, 2016 | 47159000 | 216080000 |
| Sunday, January 1, 2017 | 89912000 | 241203000 |
| Monday, January 1, 2018 | 74908000 | 214109000 |
| Tuesday, January 1, 2019 | 219750000 | 204890000 |
| Wednesday, January 1, 2020 | 492853000 | 227976000 |
| Friday, January 1, 2021 | 844287000 | 356128000 |
| Saturday, January 1, 2022 | 1037418000 | 426409000 |
| Sunday, January 1, 2023 | 1828292000 | 837999000 |
| Monday, January 1, 2024 | 2248243000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, Alnylam Pharmaceuticals, Inc. and HUTCHMED (China) Limited have emerged as key players. Over the past decade, Alnylam has seen a staggering growth in revenue, skyrocketing from a modest $50 million in 2014 to an impressive $1.8 billion in 2023. This represents a remarkable 3,500% increase, underscoring its innovative prowess in RNA interference therapeutics.
Meanwhile, HUTCHMED has also demonstrated significant growth, albeit at a more measured pace. Starting at $92 million in 2014, its revenue reached $838 million by 2023, marking a substantial 810% increase. This growth reflects its strategic expansion in oncology and immunology.
Both companies have shown resilience and adaptability, navigating the challenges of the biotech sector. As they continue to innovate, their trajectories offer valuable insights into the future of global healthcare.
Gilead Sciences, Inc. or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?
GSK plc or Alnylam Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Alnylam Pharmaceuticals, Inc. or Geron Corporation: Who Leads in Yearly Revenue?
Alnylam Pharmaceuticals, Inc. or Novavax, Inc.: Who Leads in Yearly Revenue?
Dr. Reddy's Laboratories Limited and HUTCHMED (China) Limited: A Comprehensive Revenue Analysis
Revenue Insights: Bio-Techne Corporation and HUTCHMED (China) Limited Performance Compared
Comparing Revenue Performance: Cytokinetics, Incorporated or HUTCHMED (China) Limited?
Revenue Showdown: Amneal Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Who Generates More Revenue? PTC Therapeutics, Inc. or HUTCHMED (China) Limited
Revenue Insights: HUTCHMED (China) Limited and ImmunityBio, Inc. Performance Compared
HUTCHMED (China) Limited and Geron Corporation: A Comprehensive Revenue Analysis
Revenue Insights: HUTCHMED (China) Limited and BioCryst Pharmaceuticals, Inc. Performance Compared